Publications by authors named "Jennifer Bourn"

Claim this Profile
M
Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35.
Sasha J Ruiz-Torres, Jennifer R Bourn, Nancy M Benight, Brian G Hunt, Carissa Lester

Oncogene· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.
Jennifer R Bourn, Sasha J Ruiz-Torres, Brian G Hunt, Nancy M Benight, Susan E Waltz

Cancer Lett· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.
Brian G Hunt, Christina A Wicker, Jennifer R Bourn, Elyse E Lower, Vinita Takiar

Breast Cancer Res Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of carcinogen-induced bladder cancer by fluorocoxib A.
Jennifer Bourn, Kusum Rathore, Robert Donnell, Wesley White, Md Jashim Uddin

BMC Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A.
Jennifer Bourn, Sony Pandey, Jashim Uddin, Lawrence Marnett, Maria Cekanova

Oncotarget· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
Jennifer Bourn, Maria Cekanova

Drug Des Devel Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells.
Sony Pandey, Jennifer Bourn, Maria Cekanova

Oncotarget· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.
Dmitriy Smolensky, Kusum Rathore, Jennifer Bourn, Maria Cekanova

J Cell Biochem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis